Underreporting of Hemorrhagic Stroke Associated With Phenylpropanolamine
La Grenade, Lois
Graham, David J.
JAMA: The Journal of the American Medical Association 2001 December 26; 286(24): 3081
Showing items related by title, author, creator and subject.
The Informed Consent Process and the Use of the Exception to Informed Consent in the Clinical Trial of Diaspirin Cross-Linked Hemoglobin (DCLHb) in Severe Traumatic Hemorrhagic Shock Sloan, Edward P.; Koenigsberg, Max; Houghton, Jaime; Gens, David; Cipolle, Mark; Runge, Jeffrey; Mallory, Mary Nan; Rodman, George, Jr. (DCLHb [Diaspirin Cross-linked Hemoglobin] Traumatic Hemorrhagic Shock Study Group, 1999-12)
"Two Per Cent Isn't a Lot, but When It Comes to Death It Seems Quite a Lot Anyway": Patients' Perception of Risk and Willingness to Accept Risks Associated With Thrombolytic Drug Treatment for Acute Stroke Mangset, Margrete; Berge, E.; F rde, R.; Nessa, J.; Wyller, T.B. (2009-01)BACKGROUND: Thrombolytic drugs to treat an acute ischaemic stroke reduce the risk of death or major disability. The treatment is, however, also associated with an increased risk of potentially fatal intracranial bleeding. ...